Cart
sales@molnova.com
Home -
Products -
Endocrinology/Hormones -
Opioid Receptor -
beta-Neoendorphin acetate(77739-21-0 free base)
beta-Neoendorphin acetate(77739-21-0 free base)
CAS No. 78658-39-6
beta-Neoendorphin acetate(77739-21-0 free base)( —— )
Catalog No. M37922 CAS No. 78658-39-6
beta-Neoendorphin acetate is an agonist of κ-opioid receptor
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 287 | In Stock |
|
| 10MG | 430 | In Stock |
|
| 25MG | 710 | In Stock |
|
| 50MG | 977 | In Stock |
|
| 100MG | 1321 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2632 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namebeta-Neoendorphin acetate(77739-21-0 free base)
-
NoteResearch use only, not for human use.
-
Brief Descriptionbeta-Neoendorphin acetate is an agonist of κ-opioid receptor
-
Descriptionbeta-Neoendorphin acetate is an agonist of κ-opioid receptor
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOpioid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number78658-39-6
-
Formula Weight1160.34
-
Molecular FormulaC56H81N13O14
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C[C@H](NC([C@@H](NC(CNC(CNC([C@@H](N)CC1=CC=C(O)C=C1)=O)=O)=O)CC2=CC=CC=C2)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N3CCC[C@H]3C(O)=O)=O)CC4=CC=C(O)C=C4)=O)CCCCN)=O)CCC/N=C(N)\N)=O)C.CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Cebranopadol
Cebranopadol (GRT-6005, GRT6005) is a potent analgesic nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonist with Ki/EC50 of 0.9/13 nM (human NOP receptor), 0.7/1.2 nM (mu-opioid receptor).
-
LY2795050
LY2795050 is a novel specific κ-Opioid Receptor antagonist (IC50: 0.72 nM).
-
(-)-U-50488 hydrochl...
The more active enantiomer of (±)-U-50488, a potent, selective kappa-opioid receptor agonist with no μ-opioid antagonist effects.
